Cosciens Biopharma Inc (CSCI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 08/31
(Values in U.S. thousands)
| 11-1996 | 08-1996 | 05-1996 | 02-1996 | 11-1995 | |
| Assets | |||||
| Current Assets | |||||
| Other current assets | 4,910 | 5,424 | 4,928 | 5,593 | 5,909 |
| TOTAL | $4,910 | $5,424 | $4,928 | $5,593 | $5,909 |
| Non-Current Assets | |||||
| PPE Net | 4,131 | 4,830 | 4,020 | 3,101 | 2,805 |
| Other Non-Current Assets | 6,191 | 5,654 | 5,707 | 5,810 | 6,019 |
| TOTAL | $10,322 | $10,484 | $9,727 | $8,911 | $8,824 |
| Total Assets | $15,232 | $15,908 | $14,655 | $14,504 | $14,733 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 1,386 | 1,382 | 1,038 | 689 | 2,271 |
| Accounts payable and accrued liabilities | 1,856 | 2,224 | 2,511 | 2,676 | 3,722 |
| Accrued Expenses | 1,849 | 1,447 | 1,357 | 1,461 | 1,065 |
| Other current liabilities | 0 | 0 | 37 | 37 | 107 |
| TOTAL | $5,143 | $5,397 | $5,222 | $5,238 | $7,380 |
| Non-Current Liabilities | |||||
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $5,143 | $5,397 | $5,222 | $5,238 | $7,380 |
| Shareholders' Equity | |||||
| Common Shares | 70 | 70 | 70 | 70 | 69 |
| Other shareholders' equity | 169 | 169 | 169 | 169 | 169 |
| TOTAL | $14,266 | $14,259 | $14,259 | $14,259 | $14,259 |
| Total Liabilities And Equity | $19,409 | $19,656 | $19,481 | $19,497 | $21,639 |